gms | German Medical Science

128. Kongress der Deutschen Gesellschaft für Chirurgie

Deutsche Gesellschaft für Chirurgie

03.05. - 06.05.2011, München

Immunosuppressant-induced microvascular thrombus formation is not further aggravated by ischemia-reperfusion-injury

Meeting Abstract

Suche in Medline nach

  • Anja Püschel - Chirurgische Universitätsklinik Rostock, Klinik für Allgemeine-, Thorax-, Gefäß- und Transplantationschirurgie, Rostock
  • Brigitte Vollmar - Universität Rostock, Institut für Experimentelle Chirurgie, Rostock
  • Ernst Klar - Chirurgische Universitätsklinik Rostock, Klinik für Allgemeine-, Thorax-, Gefäß- und Transplantationschirurgie, Rostock

Deutsche Gesellschaft für Chirurgie. 128. Kongress der Deutschen Gesellschaft für Chirurgie. München, 03.-06.05.2011. Düsseldorf: German Medical Science GMS Publishing House; 2011. Doc11dgch565

DOI: 10.3205/11dgch565, URN: urn:nbn:de:0183-11dgch5657

Veröffentlicht: 20. Mai 2011

© 2011 Püschel et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: In the postoperative period following pancreas-kidney transplantation, pancreatic venous thrombosis is one of the major complications leading to allograft dysfunction and -loss. Besides ischemia-reperfusion(I/R)-injury, immunosuppressants have been implicated in the development of microvascular thrombosis.

Materials and methods: Using the skin fold chamber in C57BL/6J-mice, microvascular thrombus formation was induced photochemically and quantitatively analyzed by intravital fluorescence microscopy (IVM). Animals without I/R received NaCl 0,9% (10ml/kg/d ip;n=7), Tacrolimus (TAC 10mg/kg/d ip,n=7) and Cyclosporine (CsA 5mg/kg/d ip,n=6) on 3 consecutive days or ATG (4mg/kg ip,n=8) as bolus. Additionally, the influence of a 4-h cold ischemia was examined in mice receiving NaCl (NaCl-I/R,n=6), Tacrolimus (TAC-I/R,n=5), Cyclosporine (CsA-I/R,n=5) or ATG (ATG-I/R,n=5). IVM-analysis was performed 24hrs after reperfusion. Moreover, sVCAM, sP- and sE-Selectin as well as ADMA-plasma levels were measured by ELISA.

Results: In non-ischemic tissue, microvascular thrombus formation was significantly enhanced after application of TAC, CsA and ATG compared to saline-treated mice (arteriolar and venular occlusion: TAC 251±101s and 179±27s, CsA 346±25 and 177±12, ATG 310±49 and 220±23 vs. NaCl 888±123s and 708±141s; p<0,05). I/R-injury significantly accelerated thrombosis in NaCl-treated mice (arteriolar and venular occlusion: NaCl-I/R 520±94 und 380±39s vs. NaCl 888±123 und 708±141s, p<0,05). However, the kinetic of thrombus formation induced by TAC, CsA or ATG in non-ischemic tissue was not further accelerated after I/R. Plasma concentrations of sVCAM-1, sP- and sE-selectin were significantly increased after ATG application whereas TAC-treatment significantly elevated ADMA-plasma-levels in non-ischemic animals. In mice undergoing I/R-injury, sP-selectin plasma levels were significantly increased, the ADMA-plasma-concentrations, however, were reduced compared to non-ischemic mice.

Conclusion: The present results show that application of Tacrolimus, Cyclosporine and ATG significantly enhances microvascular thrombus formation in a skinfold chamber model in mice, most likely by influencing the NO-system and platelet activation, respectively. Cold-I/R-injury accelerates thrombus formation but does not further aggravate the thrombogenic effect of the immunosuppressants.